The UK’s medicine regulator has recommended halting the rollout of the Oxford/AstraZeneca’s COVID-19 vaccine to people aged under-30.
The Medicines and Healthcare products Regulatory Agency (MHRA) said there were still huge benefits of the vaccine in preventing Covid-19 and serious disease.
However, due to a very small number of blood clots in younger people, those under the age of 30 will be offered Pfizer or Moderna instead.
England’s deputy chief medical officer Professor Jonathan Van-Tam said the changes being proposed to the vaccination rollout were a “course correction”.
Dr. June Raine, chief executive of the MHRA told a briefing the clots were “extremely rare” and the benefits of the jab were clear.